T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells

被引:395
|
作者
Fahlén, L
Read, S
Gorelik, L
Hurst, SD
Coffman, RL
Flavell, RA
Powrie, F
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
[2] Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA
[3] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
[4] Dynavax Technol Corp, Albany, CA 94710 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2005年 / 201卷 / 05期
基金
英国惠康基金;
关键词
D O I
10.1084/jem.20040685
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+)CD25(+) regulatory T (T reg) cells play a pivotal role in control of the immune response. Transforming growth factor-beta (TGF-beta) has been shown to be required for T reg cell activity; however, precisely how it is involved in the mechanism of suppression is poorly understood. Using the T cell transfer model of colitis, we show here that CD4(+)CD45RB(high) T cells that express a dominant negative TGF-beta receptor type II (dnT beta RII) and therefore cannot respond to TGF-beta, escape control by T reg cells in vivo. CD4(+)CD25(+) T reg cells from the thymus of dnT beta RII mice retain the ability to inhibit colitis, suggesting that T cell responsiveness to TGF-beta is not required for the development or peripheral function of thymic-derived T reg cells. In contrast, T reg cell activity among the peripheral dnT beta RII CD4(+)CD25(+) population is masked by the presence of colitogenic effector cells that cannot be suppressed. Finally, we show that CD4(+)CD25(+) T reg cells develop normally in the absence of TGF-beta 1 and retain the ability to suppress colitis in vivo. Importantly, the function of TGF-beta 1(-/-) T reg cells was abrogated by anti-TGF-beta monoclonal antibody, indicating that functional TGF-beta can be provided by a non-T reg cell source.
引用
收藏
页码:737 / 746
页数:10
相关论文
共 50 条
  • [21] CD4+CD25+ T cells as immunoregulatory T cells in vitro
    Chai, JG
    Tsang, JYS
    Lechler, R
    Simpson, E
    Dyson, J
    Scott, D
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (08) : 2365 - 2375
  • [22] CD4+CD25+ T Regulatory Cells in Transplantation Tolerance: 25 Years On
    Hall, Bruce M.
    TRANSPLANTATION, 2016, 100 (12) : 2533 - 2547
  • [23] Role of IL-10 and TGF-β in the suppression of allergic contact dermatitis by CD4+CD25+ regulatory T cells
    Ring, S
    Mahnke, K
    Schaefer, S
    Lehr, H
    Enk, AH
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A110 - A110
  • [24] Natural Cd4+cd25+ regulatory T cells control the development of atherosclerosis in mice
    Oufella, HA
    Potteaux, S
    Salomon, B
    Gourdy, P
    Esposito, B
    Klatzmann, D
    Tedgui, A
    Mallat, Z
    CIRCULATION, 2005, 112 (17) : U73 - U73
  • [25] CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
    Yasmine Belkaid
    Ciriaco A. Piccirillo
    Susana Mendez
    Ethan M. Shevach
    David L. Sacks
    Nature, 2002, 420 : 502 - 507
  • [26] CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
    Belkaid, Y
    Piccirillo, CA
    Mendez, S
    Shevach, EM
    Sacks, DL
    NATURE, 2002, 420 (6915) : 502 - 507
  • [27] TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells
    Marie, JC
    Letterio, JJ
    Gavin, M
    Rudensky, AY
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (07): : 1061 - 1067
  • [28] CTLA-4 is essential for TGF-β to induce CD4+CD25+ regulatory T cells that express FoxP3
    Zheng, SG
    Wang, JH
    Kim, KS
    Stohl, W
    Horwitz, DA
    FASEB JOURNAL, 2005, 19 (04): : A909 - A909
  • [29] CTLA-4.Ig converts naive CD4+CD25- t cells into CD4+CD25+ regulatory t cells
    Razmara, Marjaneh
    Hilliard, Brendan
    Ziarani, Azadeh K.
    Chen, Youhai H.
    Tykocinski, Mark L.
    INTERNATIONAL IMMUNOLOGY, 2008, 20 (04) : 471 - 483
  • [30] Human CD4+CD25+ regulatory T cells and infectious tolerance
    Stassen, M
    Schmitt, E
    Jonuleit, H
    TRANSPLANTATION, 2004, 77 (01) : S23 - S25